A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study

Sang‐Cheol Bae, Jinseok Kim, Jung‐Yoon Choe, Won Park, Sang‐Heon Lee, Yong‐Beom Park, Seung Cheol Shim, Shin‐Seok Lee, Yoon‐Kyoung Sung, Chan‐Bum Choi,

Annals of the Rheumatic Diseases · 2016 · 42 citations · 25 references

DOIFull text

Open access

Concepts

References

25